Latest Oklahoma News

Imagion Biosystems has made significant strides toward filing an IND application for its MagSense® HER2 breast cancer imaging agent, supported by positive FDA feedback and a recent $3.5 million capital raise to fund upcoming clinical trials.

AXP Energy has successfully logged hydrocarbons across several zones in its Charlie #1 well in Oklahoma and is preparing for hydraulic fracturing with production expected by the end of October.

AXP Energy has successfully reached the target depth in its Charlie #1 well, revealing over 290 feet of promising oil and gas shows across multiple formations. The company is now preparing for detailed logging to assess commercial viability.

AXP Energy reports encouraging oil and gas shows in its first Oklahoma well, Charlie #1, signaling potential for expanded production and gas-to-power operations.

AXP Energy has commenced drilling operations on its Charlie #1 Well in Oklahoma, backed by a recent A$2.7 million capital raise. The project targets multiple stacked pay zones and aims to expand gas-to-power and bitcoin mining ventures.

AXP Energy has updated its resource disclosures and is accelerating its gas-to-power strategy to fuel bitcoin mining operations in Oklahoma, leveraging proven oil fields and strong industry partnerships.

AXP Energy has secured 1,400 acres of oil and gas leases in Kay County, Oklahoma, setting the stage for rapid drilling and expansion of its gas-to-power-bitcoin mining operations. The company aims to leverage proven stacked pay zones and a favorable regulatory environment to scale production and innovative energy uses.

AXP Energy has raised A$2.7 million through a two-tranche placement to expand its innovative gas-to-power-bitcoin mining operations and accelerate oil and gas drilling activities in Oklahoma.

Brookside Energy Limited reported a strong quarter with the Bruins well commencing production, solid contributions from Gapstow wells, and a disciplined capital strategy including a new share buy-back program.

Imagion Biosystems has made significant progress towards filing an Investigational New Drug application for its MagSense® HER2 breast cancer imaging agent, receiving encouraging feedback from the FDA and preparing for a Phase 2 clinical trial.

Brookside Energy reports robust early production from its ninth horizontal well in the SWISH Play, delivering solid cash flow and promising project economics.

Imagion Biosystems has received encouraging feedback from the FDA on its MagSense HER2 breast cancer imaging program, clearing the path for a Phase 2 clinical trial and fast-tracking manufacturing.